{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:26:22Z","timestamp":1787109982918,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019000","name":"Ministry of National Defense Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MND-MAB-D-112128"],"award-info":[{"award-number":["MND-MAB-D-112128"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-E-112235"],"award-info":[{"award-number":["TSGH-E-112235"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC114-2314-B016-054-MY3"],"award-info":[{"award-number":["NSTC114-2314-B016-054-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC113-2314-B016-035"],"award-info":[{"award-number":["NSTC113-2314-B016-035"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC112-2314-B016-025"],"award-info":[{"award-number":["NSTC112-2314-B016-025"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejps.2026.107608","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:06:14Z","timestamp":1784214374000},"page":"107608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PLCG1 and RAC1 orchestrate adaptive cellular programs driving osimertinib-tolerant persister cell formation in malignant pleural effusion\u2013associated non\u2013small cell lung cancer"],"prefix":"10.1016","volume":"225","author":[{"given":"Tung-Yu","family":"Tiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Yung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ying","family":"Changchien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih\u2011Feng","family":"Chian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9783-5423","authenticated-orcid":false,"given":"Chen-Liang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107608_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1053574","article-title":"Malignant pleural effusion: updates in diagnosis, management and current challenges","volume":"12","author":"Addala","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.ejps.2026.107608_bib0002","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1126\/science.1099390","article-title":"Bacterial persistence as a phenotypic switch","volume":"305","author":"Balaban","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ejps.2026.107608_bib0003","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.chest.2024.07.183","article-title":"Impact of dyspnea on adults with Respiratory symptoms without a defined diagnosis","volume":"166","author":"Bierbrier","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.ejps.2026.107608_bib0004","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(00)74210-3","article-title":"Treatment of staphyloeoeeal infections with penicillin by intermittent sterilisation","author":"Bigger","year":"1944","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2026.107608_bib0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-physiol-021119-034627","article-title":"The acidic tumor microenvironment as a driver of cancer","volume":"82","author":"Boedtkjer","year":"2020","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejps.2026.107608_bib0006","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41419-020-03175-5","article-title":"Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy","volume":"11","author":"Cerezo","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejps.2026.107608_bib0007","article-title":"Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients","volume":"7","author":"Chabon","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2026.107608_bib0008","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc3775","article-title":"Non-small-cell lung cancers: a heterogeneous set of diseases","volume":"14","author":"Chen","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejps.2026.107608_bib0009","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1158\/0008-5472.CAN-14-3167","article-title":"Acquired resistance to the mutant-selective EGFR inhibitor AZD9291 is associated with increased dependence on RAS signaling in preclinical models","volume":"75","author":"Eberlein","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2026.107608_bib0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41598-017-00508-x","article-title":"IL-1\u03b2 induced HIF-1\u03b1 inhibits the differentiation of human FOXP3+ T cells","volume":"7","author":"Feldhoff","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107608_bib0011","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12931-024-02684-7","article-title":"Malignant pleural effusion: current understanding and therapeutic approach","volume":"25","author":"Gonnelli","year":"2024","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejps.2026.107608_bib0012","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ccell.2017.07.002","article-title":"Repression of stress-induced LINE-1 expression protects cancer cell subpopulations from lethal drug exposure","volume":"32","author":"Guler","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejps.2026.107608_bib0013","first-page":"809","article-title":"Lung cancer: current diagnosis and treatment","volume":"106","author":"Hammerschmidt","year":"2009","journal-title":"Dtsch. \u00c4rztebl. Int."},{"key":"10.1016\/j.ejps.2026.107608_bib0014","first-page":"1284","article-title":"Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism","volume":"8","author":"Helmlinger","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2026.107608_bib0015","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMoa1411817","article-title":"AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer","volume":"372","author":"Janne","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2026.107608_bib0016","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1073\/pnas.0502860102","article-title":"Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib","volume":"102","author":"Kwak","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2026.107608_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54788-9","article-title":"Cell polarity proteins promote macropinocytosis in response to metabolic stress","volume":"15","author":"Lambies","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejps.2026.107608_bib0018","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1038\/s41598-020-63996-4","article-title":"New screening system using Twist1 promoter activity identifies dihydrorotenone as a potent drug targeting cancer-associated fibroblasts","volume":"10","author":"Lee","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107608_bib0019","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejps.2026.107608_bib0020","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2026.107608_bib0021","first-page":"10","article-title":"T790M and acquired resistance of EGFR TKI: a literature review of clinical reports","volume":"3","author":"Ma","year":"2011","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.ejps.2026.107608_bib0022","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/CMAR.S95663","article-title":"Management of malignant pleural effusion: challenges and solutions","volume":"9","author":"Penz","year":"2017","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ejps.2026.107608_bib0023","doi-asserted-by":"crossref","unstructured":"Piggott, L.M., Hayes, C., Greene, J., Fitzgerald, D.B., 2024. Malignant pleural disease. 19, 230145.","DOI":"10.1183\/20734735.0145-2023"},{"key":"10.1016\/j.ejps.2026.107608_bib0024","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10555-019-09792-7","article-title":"Causes, consequences, and therapy of tumors acidosis","volume":"38","author":"Pillai","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ejps.2026.107608_bib0025","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1093\/annonc\/mdv319","article-title":"EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patients","volume":"26","author":"Planchard","year":"2015","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.ejps.2026.107608_bib0026","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/16000617.0019-2016","article-title":"Malignant pleural effusion: from bench to bedside","volume":"25","author":"Psallidas","year":"2016","journal-title":"Eur. Respir. Rev.: Off. J. Eur. Respir. Soc."},{"key":"10.1016\/j.ejps.2026.107608_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10690","article-title":"Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells","volume":"7","author":"Ramirez","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2026.107608_bib0028","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fendo.2017.00261","article-title":"Macropinocytosis: a metabolic adaptation to nutrient stress in cancer","volume":"8","author":"Recouvreux","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ejps.2026.107608_bib0029","first-page":"3495","article-title":"Multiplexed molecular profiling of lung cancer with malignant pleural effusion using next generation sequencing in Chinese patients","volume":"19","author":"Ruan","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejps.2026.107608_bib0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12915-022-01340-0","article-title":"Proton export upregulates aerobic glycolysis","volume":"20","author":"Russell","year":"2022","journal-title":"BMC Biol."},{"key":"10.1016\/j.ejps.2026.107608_bib0031","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejps.2026.107608_bib0032","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3892\/ijo.2023.5584","article-title":"Acidosis promotes the metastatic colonization of lung cancer via remodeling of the extracellular matrix and vasculogenic mimicry","volume":"63","author":"Shie","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejps.2026.107608_bib0033","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1349-7006.2011.01887.x","article-title":"Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: a pooled analysis of published reports","volume":"102","author":"Shukuya","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejps.2026.107608_bib0034","article-title":"Malignant pleural effusion and its current management: a review","volume":"55","author":"Skok","year":"2019","journal-title":"Med. (Kaunas Lith.)"},{"key":"10.1016\/j.ejps.2026.107608_bib0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12943-018-0778-0","article-title":"Third generation EGFR TKIs: current data and future directions","volume":"17","author":"Tan","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejps.2026.107608_bib0036","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12920-025-02180-x","article-title":"Driver mutations and malignant pleural effusion in non-small cell lung cancer","volume":"18","author":"Temel","year":"2025","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.ejps.2026.107608_bib0037","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nm.3854","article-title":"Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M","volume":"21","author":"Thress","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2026.107608_bib0038","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12885-020-6593-1","article-title":"Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy","volume":"20","author":"Tokudome","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejps.2026.107608_bib0039","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2009.11.022","article-title":"Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC","volume":"17","author":"Turke","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejps.2026.107608_bib0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12943-018-0777-1","article-title":"Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer","volume":"17","author":"Wu","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejps.2026.107608_bib0041","article-title":"Malignant pleural effusion diagnosis and therapy","volume":"18","author":"Yang","year":"2023","journal-title":"Open life Sci."},{"key":"10.1016\/j.ejps.2026.107608_bib0042","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.ejps.2026.107608_bib0043","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/JTO.0b013e31829f691f","article-title":"High T790M detection rate in TKI-naive NSCLC with EGFR sensitive mutation: truth or artifact?","volume":"8","author":"Ye","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ejps.2026.107608_bib0044","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-019-0099-9","article-title":"The emerging treatment landscape of targeted therapy in non-small-cell lung cancer","volume":"4","author":"Yuan","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejps.2026.107608_bib0045","doi-asserted-by":"crossref","first-page":"33403","DOI":"10.18632\/oncotarget.23607","article-title":"Cancer stem cells in progression of colorectal cancer","volume":"9","author":"Zhou","year":"2018","journal-title":"Oncotarget"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872600182X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872600182X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:42:41Z","timestamp":1787107361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809872600182X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"alternative-id":["S092809872600182X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107608","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PLCG1 and RAC1 orchestrate adaptive cellular programs driving osimertinib-tolerant persister cell formation in malignant pleural effusion\u2013associated non\u2013small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107608"}}